Metformin revisited: re‐evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents

Metformin revisited: re‐evaluation of its properties and role in the pharmacopoeia of modern... Background:  The usefulness of metformin as an oral antidiabetic agent is widely accepted. However, several other classes of oral antidiabetic agents have been recently introduced, raising the need to evaluate the role of metformin as initial therapy and in combination with these newer drugs for treatment of type 2 diabetes mellitus (DM). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetes Obesity & Metabolism Wiley

Metformin revisited: re‐evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents

Loading next page...
 
/lp/wiley/metformin-revisited-re-evaluation-of-its-properties-and-role-in-the-oIyjNIhPqW
Publisher
Wiley
Copyright
Copyright © 2005 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1462-8902
eISSN
1463-1326
DOI
10.1111/j.1463-1326.2004.00448.x
pmid
16219009
Publisher site
See Article on Publisher Site

Abstract

Background:  The usefulness of metformin as an oral antidiabetic agent is widely accepted. However, several other classes of oral antidiabetic agents have been recently introduced, raising the need to evaluate the role of metformin as initial therapy and in combination with these newer drugs for treatment of type 2 diabetes mellitus (DM).

Journal

Diabetes Obesity & MetabolismWiley

Published: Nov 1, 2005

Keywords: ; ; ; ;

References

  • Biguanide treatment in the management of non‐insulin‐independent (maturity‐onset) diabetes: clinical experience with metformin
    Clarke, BF; Duncan, LJ
  • The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non‐insulin‐dependent diabetes mellitus
    Campbell, IW; Duncan, C; Patton, NW
  • Impaired beta‐cell responses improve when fasting blood glucose concentration is reduced in non‐insulin‐dependent diabetes
    Ferner, RE; Rawlins, MD; Alberti, KG
  • Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double‐blind controlled study
    Hermann, LS; Schersten, B; Bitzen, PO
  • Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin‐induced diabetes and effects of metformin
    Large, V; Beylot, M
  • Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver
    Radziuk, J; Zhang, Z; Wiernsperger, N; Pye, S
  • Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial
    Fonseca, V; Rosenstock, J; Patwardhan, R; Salzman, A
  • Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
    Velazquez, EM; Mendoza, S; Hamer, T; Sosa, F; Glueck, CJ
  • Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non‐insulin dependent diabetes followed for three years (UKPDS 13)
  • Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
    Johnson, JA; Majumdar, SR; Simpson, SH; Toth, EL
  • Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis
    Denno, KM; Sadler, TW
  • Effects of metformin on spontaneous and clomiphene‐induced ovulation in the polycystic ovary syndrome
    Nestler, JE; Jakubowicz, DJ; Evans, WS; Pasquali, R
  • Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome
    Batukan, C; Baysal, B
  • Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome
    Glueck, CJ; Wang, P; Kobayashi, S; Phillips, H; Sieve‐Smith, L
  • Effects of metformin on early pregnancy loss in the polycystic ovary syndrome
    Jakubowicz, DJ; Iuorno, MJ; Jakubowicz, S; Roberts, KA; Nestler, JE
  • Efficacy and safety of acarbose in metformin‐treated patients with type 2 diabetes
    Rosenstock, J; Brown, A; Fischer, J
  • Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
    Inzucchi, SE; Maggs, DG; Spollett, GR
  • Addition of rosiglitazone to metformin is most effective in obese, insulin‐resistant patients with type 2 diabetes
    Jones, TA; Sautter, M; Van Gaal, LF; Jones, NP
  • Efffect of addition of low‐dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2 diabetic patients
    Yang, J; Di, F; He, R

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off